Filter
508
Text search:
drug
interactions
Featured
Recommendations
51
New Publications
101
Language
Document type
No document type
303
Studies & Reports
74
Guidelines
73
Manuals
22
Training Material
14
Fact sheets
12
Strategic & Response Plan
8
Situation Updates
2
Countries / Regions
India
22
Kenya
17
Global
17
South Africa
13
Ethiopia
11
Nigeria
10
Ghana
10
Rwanda
10
Western and Central Europe
10
Latin America and the Carribbean
9
Uganda
8
Nepal
8
Tanzania
8
Malawi
7
Ukraine
7
Sierra Leone
6
Zambia
6
Africa
6
Liberia
5
Russia
5
USA
4
Bangladesh
4
South–East Asia Region
4
Eastern Europe
4
Zimbabwe
3
Philippines
3
Cambodia
3
Botswana
3
Lesotho
3
West and Central Africa
3
South Sudan
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
United Kingdom
2
Senegal
1
Afghanistan
1
Germany
1
Syria
1
Thailand
1
Mozambique
1
Sudan
1
Namibia
1
Eswatini/ Swaziland
1
Colombia
1
Sri Lanka
1
Chile
1
Albania
1
Laos
1
Tajikistan
1
Estonia
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
142
Clinical Guidelines
60
Public Health
29
Women & Child Health
15
Key Resources
10
Capacity Building
8
Toolboxes
Mental Health
82
TB
61
HIV
59
AMR
28
COVID-19
20
NTDs
19
Pharmacy
18
Planetary Health
14
Caregiver
11
Disability
9
Refugee
8
NCDs
8
Global Health Education
7
Ebola & Marburg
5
Rapid Response
5
Polio
3
Malaria
3
Conflict
2
Cholera
1
Natural Hazards
1
Social Ethics
1
2.0 Rapid Response
1
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitroheterocyclic drugs, benznidazole and nifurtimox, are cu
...
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Southern Med Review (2009)2;1:2-6
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Strategic Overview
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
10 years after the UN general assembly special session on drugs
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P
...
Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB
Results of the first national survey, 2013–2014
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
